Department of Otorhinolaryngology, the Affiliated Hospital of Medical School, Ningbo University, Ningbo, China.
Department of Otorhinolaryngology, Ningbo Traditional Chinese Medicine Hospital, 3rd Clinical Medical School of Zhejiang University of Chinese Medicine, Ningbo, China.
ORL J Otorhinolaryngol Relat Spec. 2022;84(4):347-351. doi: 10.1159/000519724. Epub 2021 Dec 20.
Recent guidelines have revealed that eosinophilic chronic rhinosinusitis (ECRS) exhibits a strong tendency for recurrence after surgery and impairs quality of life. Neuropeptides play an important neuroimmunological role. The aim of this study was to determine the efficacy of posterior nasal neurectomy (PNN) for the treatment of ECRS by inhibiting type 2 cytokine expression.
Forty-six patients were divided into group A and group B according to a random number table. Group A underwent conventional functional endoscopic sinusitis surgery (FESS) combined with PNN, and group B underwent conventional FESS alone. The subjective and objective symptoms included a 10-cm visual analog scale (VAS), 22-item SinoNasal Outcome Test (SNOT-22) score, nasal speculum Lund-Kennedy score, and paranasal sinus computed tomography (CT) Lund-Mackay score at the 1-year postoperative follow-up.
Postoperative VAS (10.33 ± 2.18 vs. 8.38 ± 2.11, p < 0.01) and Lund-Kennedy score (1.95 ± 1.32 vs. 3.14 ± 1.35, p < 0.01) were significantly improved. The rhinorrhea score (1.76 ± 0.83 vs. 2.90 ± 1.14, p < 0.001) in the VAS and the discharge (0.43 ± 0.51, vs. 0.95 ± 0.67, p < 0.01) and edema (0.57 ± 0.60 vs. 0.95 ± 0.59, p < 0.05) scores in the Lund-Kennedy score were observed to have improved significantly in group A compared with those in group B.
FESS combined with PNN suppresses edema symptoms, which might significantly decrease the surgical recurrence rate of ECRS in the long term.
最近的指南表明,嗜酸性慢性鼻鼻窦炎(ECRS)在手术后有很强的复发倾向,并损害生活质量。神经肽在神经免疫中发挥重要作用。本研究旨在通过抑制 2 型细胞因子表达来确定后鼻神经切除术(PNN)治疗 ECRS 的疗效。
46 例患者根据随机数字表分为 A 组和 B 组。A 组行常规功能性内镜鼻窦手术(FESS)联合 PNN,B 组行单纯常规 FESS。术后 1 年随访时采用 10cm 视觉模拟量表(VAS)、22 项鼻-鼻窦炎结局测试(SNOT-22)评分、鼻镜 Lund-Kennedy 评分和鼻窦 CT(Lund-Mackay)评分评估主观和客观症状。
术后 VAS(10.33±2.18 比 8.38±2.11,p<0.01)和 Lund-Kennedy 评分(1.95±1.32 比 3.14±1.35,p<0.01)显著改善。VAS 中流涕评分(1.76±0.83 比 2.90±1.14,p<0.001)和 Lund-Kennedy 评分中分泌物(0.43±0.51 比 0.95±0.67,p<0.01)和水肿(0.57±0.60 比 0.95±0.59,p<0.05)评分明显改善。
FESS 联合 PNN 可抑制水肿症状,长期来看可能显著降低 ECRS 的手术复发率。